Cognex Corporation
NASDAQ:CGNXHardware, Equipment & Parts
-$0.64 today
- Market cap
- $8.27B
- Beta
- 1.51
- P/E (TTM)
- 75.7
- EPS (TTM)
- $0.86
- Dividend yield
- 0.52%
Volume 1.61M
Average 2.14M
CGNX Deferred Revenue
Payments received for goods or services the company will deliver within the next year.
Cognex CorporationNASDAQ: CGNX
Deferred Revenue · Q3 FY2026 · quarter ended Oct 2026
Deferred revenue rises 78.6% from a year ago
Deferred revenue stood at $42.45M at the end of Q3 FY2026, up 78.6% from a year earlier and down 13.3% from the prior quarter. Over 3 fiscal years it compounded at -19.7% a year.
Context
- Deferred revenue amounted to 1.9% of total assets at the end of Q3 FY2026, up 0.7 pp from a year earlier.
- Deferred revenue increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether deferred revenue keeps rising in the next quarterly balance sheet after a +78.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Deferred Revenue history
USD · from the balance sheet
- Latest · FY2025
- 21.09M USD
- Year-over-year change
- -15.7%
- 4-year CAGR
- -12.4%
| Period | Period end | Deferred Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 21.09M | -15.7% |
| FY2024 | 2024-12-31 | 25.04M | -20.6% |
| FY2023 | 2023-12-31 | 31.53M | -22.7% |
| FY2022 | 2022-12-31 | 40.79M | +14.1% |
| FY2021 | 2021-12-31 | 35.74M | — |
Deferred Revenue vs competitors
How CGNX compares with its peers on the latest reported figures
- CGNX's Oct 2026 deferred revenue of $42.45M is the 2nd highest of the 5 companies compared; the peer median is $20.97M.
- Its year-over-year change of +78.6% is the 2nd highest of 4, against a peer median of +30.9%.
- Deferred revenue amounts to 1.9% of total assets for CGNX, versus a peer median of 0.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jul 2026 | $444M | -2.8% | +1.6% | 5.1% | |
| Oct 2026 | $42.45M | +78.6% | -19.7% | 1.9% | |
| Oct 2026 | $41.53M | +417.1% | — | 1.3% | |
| Mar 2026 | $411K | +30.9% | — | 0.4% | |
| Sep 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding CGNX) | $20.97M | +30.9% | +1.6% | 0.8% | |
Competitors are the stored peer set for CGNX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 186.16M | 181.37M | 202.66M | 186.09M | 262.93M |
| Short-term Investments | 137.46M | 218.76M | 129.39M | 59.96M | 74.04M |
| Net Receivables | 134.34M | 127.6M | 116.57M | 146.41M | 163.69M |
| Inventory | 113.1M | 122.48M | 162.29M | 157.53M | 137.89M |
| Other Current Assets | 0 | 67.49M | 68.1M | 63.38M | 58.7M |
| Total Current Assets | 639.8M | 717.7M | 679M | 613.37M | 697.25M |
| Property, Plant & Equipment (Net) | 100.7M | 117.4M | 180.96M | 165.77M | 158.33M |
| Goodwill | 241.71M | 242.63M | 393.18M | 384.94M | 386.28M |
| Intangible Assets | 11.89M | 12.41M | 112.95M | 90.68M | 81.1M |
| Long-term Investments | 583.75M | 454.12M | 244.23M | 340.9M | 305.34M |
| Tax Assets | 418.57M | 407.24M | 400.4M | 392.17M | 383.27M |
| Other Non-current Assets | 7.24M | 6.64M | 7.09M | 5.03M | 4.99M |
| Total Non-current Assets | 1.36B | 1.24B | 1.34B | 1.38B | 1.32B |
| Total Assets | 2B | 1.96B | 2.02B | 1.99B | 2.02B |
| Account Payables | 44.05M | 27.1M | 21.45M | 38.05M | 50.2M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 8.58M | 18.13M | 16.91M | 25.69M | 9.14M |
| Deferred Revenue | 35.74M | 40.79M | 31.53M | 25.04M | 21.09M |
| Other Current Liabilities | 50.92M | 49.4M | 27.72M | 34.32M | 51.89M |
| Total Current Liabilities | 188.59M | 187.71M | 151.88M | 169.38M | 183.55M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 308.55M | 265.83M | 273.56M | 243.52M | 274.78M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 58.64M | 34.91M | 18.64M | 1.08M | 1.45M |
| Total Non-current Liabilities | 384.98M | 332.04M | 361.18M | 305.97M | 341.1M |
| Total Liabilities | 573.57M | 519.75M | 513.06M | 475.35M | 524.65M |
| Common Stock | 351K | 345K | 343K | 341K | 334K |
| Retained Earnings | 562.88M | 528.18M | 512.54M | 499.3M | 406.36M |
| Accumulated OCI | (47.94M) | (69.3M) | (45.34M) | (72.78M) | (53.5M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 1.43B | 1.44B | 1.5B | 1.52B | 1.49B |
| Total Debt | 25.58M | 39.75M | 78.6M | 70.22M | 76.59M |
| Net Debt | (160.58M) | (141.62M) | (124.05M) | (115.88M) | (186.34M) |
Cognex Corporation
NASDAQ:CGNX
Intrinsic Alpha fair value
Locked
Current Price
$49.13
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.